



What are they? Natural killer (NK)
cells are large, granular lymphocytes
found mainly in peripheral blood,
where they make up about 10% of
the lymphocyte population. They are
a first line of defense in the innate
immune system and may also have a
role in the adaptive immune system.
Why the provocative name? Well, it’s
easier to remember than
‘CD3-negative, CD56 and/or
CD16-positive lymphocytes’.
They first came to prominence… in the
1970s, because of their ability to
spontaneously kill certain tumour
cells.
What do they do? NK cells are
equipped with cytotoxic granules
that contain the arsenal of cytotoxic
molecules used in killing virally
infected and cancerous cells. They
recognize their targets, in part, by
means of activating signals that are
only just beginning to be identified,
but also by detecting cells that are
deficient in cell-surface class I
molecules of the major
histocompatibility complex (class I
MHC molecules). Tumour cells and
cells infected with viruses have often
lost their cell-surface MHC
molecules, which makes them
susceptible to attack. Healthy cells
displaying self-MHC molecules are
protected against attack by NK cells
(see Figure).
How do they work? When an NK cell
is triggered to kill a target cell,
cytotoxic granules are released. The
granule contents can induce either
osmotic lysis (necrosis) or suicide
(apoptosis) of the target cell.
So, what’s known about the receptors on
NK cells? Human NK cells have two
distinct types of surface receptor that
recognize class I MHC molecules:
members of the immunoglobulin
superfamily (killer cell Ig-like
receptors, or KIR), and the C-type
lectin receptors, composed of a
heterodimer of CD94 and an NKG2
protein. They interact with MHC
class I molecules in different ways
and each type of receptor has both
inhibitory and activating forms.
Inhibition dominates when both
forms are expressed in a single cell.
Diversity is a key feature of the KIR
receptors. Unfortunately, this
diversity also extends to the
nomenclature, which makes reading
the literature hard work. For example,
the names p58.1, nkat-1 and 2DL1 all
refer to one KIR receptor.
How do NK cell receptors cope with the
diversity of MHC class I molecules? In
humans, KIR receptors bind directly
to the conserved sections of
individual class I MHC molecules,
whereas the CD94–NKG2a receptor
recognises classical class I MHC
molecules indirectly, using an
adaptor molecule, the non-classical
class I MHC molecule HLA-E.
HLA-E binds the signal peptide of
some, but not all, MHC molecules.
On binding, HLA-E translocates to
the cell surface, where it interacts
with its inhibitory CD94–NKG2a
receptor (see Figure).
What else do they do?
Granule-mediated cytotoxicity is not
their only weapon; NK cells also
secrete tumor necrosis factor α and
and can express the apoptosis FasL
signal. In addition, they produce a
range of cytokines, which allows them
to regulate and participate in such
immune processes as hemopoeisis,
antibody production and early
interferon γ production in infection.
Could we live without them? Perhaps,
but probably not a long or healthy
life. There is only one documented
human case of an absolute NK cell
deficiency, which was associated with
recurrent life-threatening bacterial
and viral infections.
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(a) A healthy cell expresses class I MHC
molecules at its surface (represented here by
the human MHC molecules HLA-C and
HLA-E). These interact with receptors
(represented here by human KIR2D and
CD94–NKG2a) on the NK cell surface and
transmit an inhibitory signal to the NK cell,
thus sparing the healthy cell from lysis. The
signal peptide (red) of classical MHC class I
allows HLA-E expression on the cell surface.
(b) In a target cell (a virally infected or
cancerous cell) class I MHC may be no longer
expressed at the surface. This cell therefore
does not inhibit NK cells and is killed.
(Activating signals are less well understood
and are not shown.)
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